Kodiak Stock Soars (Again) As Data Shows Long-Lasting Eye Meds Are 'Real Deal' (KOD)
· seekingalpha.com
Kodiak Sciences Inc. stock jumps 140% on Phase 3 DAYBREAK wet AMD results. Click for this updated look at KOD and see if it belongs in your portfolio.
If you are interested in keeping up to date with stocks making moves within the biotech, pharma and healthcare industries, and understanding the key trends and ...